Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cyclic Nucleotide Phosphodiesterases, Type 3 | 3 | 2021 | 20 | 1.600 |
Why?
|
Endoribonucleases | 2 | 2024 | 226 | 0.980 |
Why?
|
Pyridazines | 3 | 2021 | 202 | 0.930 |
Why?
|
RNA, Transfer, Leu | 1 | 2022 | 13 | 0.850 |
Why?
|
Ribonucleases | 1 | 2022 | 264 | 0.770 |
Why?
|
Intracellular Signaling Peptides and Proteins | 4 | 2021 | 2870 | 0.720 |
Why?
|
Mutation | 28 | 2021 | 30006 | 0.490 |
Why?
|
Cell Transformation, Neoplastic | 10 | 2014 | 2820 | 0.430 |
Why?
|
Neoplasms | 12 | 2022 | 22125 | 0.370 |
Why?
|
Quinazolines | 12 | 2011 | 1371 | 0.360 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2011 | 191 | 0.350 |
Why?
|
NIH 3T3 Cells | 10 | 2013 | 668 | 0.330 |
Why?
|
Receptor, erbB-2 | 6 | 2013 | 2553 | 0.320 |
Why?
|
Lung Neoplasms | 19 | 2014 | 13382 | 0.320 |
Why?
|
Adenocarcinoma | 10 | 2014 | 6340 | 0.320 |
Why?
|
Cell Line, Tumor | 20 | 2022 | 16947 | 0.320 |
Why?
|
Catalytic Domain | 2 | 2021 | 702 | 0.300 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2008 | 212 | 0.280 |
Why?
|
Cell Death | 2 | 2022 | 1676 | 0.260 |
Why?
|
Phosphorylation | 13 | 2022 | 8303 | 0.240 |
Why?
|
Protein Multimerization | 3 | 2021 | 974 | 0.230 |
Why?
|
Mitogen-Activated Protein Kinases | 4 | 2008 | 1240 | 0.230 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 11 | 2012 | 5318 | 0.220 |
Why?
|
Cell Survival | 10 | 2021 | 5776 | 0.210 |
Why?
|
Endodeoxyribonucleases | 1 | 2024 | 164 | 0.210 |
Why?
|
Drug Resistance, Neoplasm | 9 | 2016 | 5300 | 0.210 |
Why?
|
Medulloblastoma | 4 | 2012 | 677 | 0.210 |
Why?
|
Protein-Tyrosine Kinases | 4 | 2008 | 2426 | 0.210 |
Why?
|
Endometrial Neoplasms | 2 | 2009 | 1365 | 0.200 |
Why?
|
Cerebellar Neoplasms | 3 | 2012 | 586 | 0.200 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 4 | 1998 | 489 | 0.190 |
Why?
|
Calorimetry, Differential Scanning | 1 | 2021 | 100 | 0.190 |
Why?
|
Tetrahydroisoquinolines | 1 | 2021 | 81 | 0.180 |
Why?
|
Genes, erbB-1 | 3 | 2008 | 162 | 0.180 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 3 | 1998 | 636 | 0.180 |
Why?
|
Retroviridae Proteins, Oncogenic | 2 | 1996 | 74 | 0.170 |
Why?
|
Adenosine Monophosphate | 1 | 2021 | 231 | 0.170 |
Why?
|
Enzyme Activation | 6 | 2015 | 3577 | 0.160 |
Why?
|
Protein Binding | 3 | 2021 | 9300 | 0.160 |
Why?
|
Protein Structure, Tertiary | 9 | 2014 | 3779 | 0.160 |
Why?
|
Protein Kinase Inhibitors | 11 | 2014 | 5662 | 0.160 |
Why?
|
Oncogenes | 3 | 2014 | 1220 | 0.160 |
Why?
|
Genome, Human | 7 | 2016 | 4423 | 0.150 |
Why?
|
Frameshift Mutation | 1 | 2020 | 392 | 0.150 |
Why?
|
Multienzyme Complexes | 1 | 2021 | 665 | 0.150 |
Why?
|
Phosphoprotein Phosphatases | 2 | 1996 | 328 | 0.150 |
Why?
|
Mutation, Missense | 5 | 2014 | 2567 | 0.150 |
Why?
|
Cryoelectron Microscopy | 1 | 2021 | 648 | 0.140 |
Why?
|
Carcinoma | 1 | 2008 | 2328 | 0.140 |
Why?
|
HeLa Cells | 2 | 2021 | 3073 | 0.130 |
Why?
|
Protein Biosynthesis | 1 | 2022 | 2091 | 0.120 |
Why?
|
HSP90 Heat-Shock Proteins | 2 | 2008 | 422 | 0.120 |
Why?
|
Cytotoxins | 1 | 2015 | 153 | 0.120 |
Why?
|
Immunoblotting | 3 | 2015 | 1644 | 0.120 |
Why?
|
Chromosome Mapping | 3 | 2016 | 4612 | 0.120 |
Why?
|
Kinetics | 2 | 2021 | 6312 | 0.120 |
Why?
|
Genome | 3 | 2020 | 1737 | 0.120 |
Why?
|
Transfection | 5 | 2008 | 5750 | 0.120 |
Why?
|
Genes, Neoplasm | 2 | 2016 | 370 | 0.120 |
Why?
|
Apoptosis | 6 | 2022 | 9478 | 0.120 |
Why?
|
Proto-Oncogene Proteins A-raf | 1 | 2014 | 9 | 0.120 |
Why?
|
Mass Spectrometry | 1 | 2021 | 2189 | 0.110 |
Why?
|
Gene Expression Regulation, Neoplastic | 8 | 2013 | 8529 | 0.110 |
Why?
|
Antineoplastic Agents | 10 | 2014 | 13630 | 0.110 |
Why?
|
Heterozygote | 1 | 2020 | 2778 | 0.110 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2011 | 256 | 0.100 |
Why?
|
Retroviridae | 2 | 2012 | 850 | 0.100 |
Why?
|
HEK293 Cells | 1 | 2021 | 4250 | 0.100 |
Why?
|
Niacinamide | 1 | 2014 | 413 | 0.100 |
Why?
|
Gene Amplification | 3 | 2011 | 1084 | 0.100 |
Why?
|
Mice | 22 | 2013 | 81324 | 0.100 |
Why?
|
Alleles | 4 | 2012 | 6857 | 0.100 |
Why?
|
Recombinant Proteins | 1 | 2021 | 6507 | 0.100 |
Why?
|
Immediate-Early Proteins | 3 | 2008 | 444 | 0.100 |
Why?
|
Receptors, Mitogen | 1 | 2011 | 61 | 0.090 |
Why?
|
STAT3 Transcription Factor | 2 | 2006 | 872 | 0.090 |
Why?
|
ras Proteins | 1 | 1996 | 1054 | 0.090 |
Why?
|
Quinolines | 2 | 2007 | 764 | 0.090 |
Why?
|
Bacterial Proteins | 1 | 2024 | 3838 | 0.090 |
Why?
|
Dimerization | 1 | 2012 | 888 | 0.090 |
Why?
|
DNA, Neoplasm | 4 | 2014 | 1743 | 0.090 |
Why?
|
Phenylurea Compounds | 1 | 2014 | 529 | 0.090 |
Why?
|
Mice, Nude | 5 | 2011 | 3604 | 0.090 |
Why?
|
Cell Division | 1 | 1998 | 4451 | 0.090 |
Why?
|
DNA-Binding Proteins | 5 | 2013 | 9566 | 0.090 |
Why?
|
DNA Primers | 2 | 2012 | 2815 | 0.090 |
Why?
|
Cell Cycle Proteins | 3 | 2013 | 3443 | 0.090 |
Why?
|
Histiocytoma, Malignant Fibrous | 1 | 2010 | 55 | 0.090 |
Why?
|
Base Sequence | 2 | 2020 | 12404 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 3 | 2013 | 475 | 0.080 |
Why?
|
Signal Transduction | 12 | 2016 | 23415 | 0.080 |
Why?
|
Neuregulin-1 | 1 | 2010 | 135 | 0.080 |
Why?
|
Receptor, erbB-3 | 1 | 2010 | 142 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2009 | 2455 | 0.080 |
Why?
|
Amino Acid Substitution | 5 | 2014 | 1737 | 0.080 |
Why?
|
Carcinoma, Adenosquamous | 1 | 2009 | 65 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 7 | 2016 | 15915 | 0.080 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2008 | 89 | 0.080 |
Why?
|
Gene Dosage | 2 | 2010 | 1217 | 0.080 |
Why?
|
Animals | 26 | 2013 | 168083 | 0.080 |
Why?
|
SOS1 Protein | 1 | 2008 | 40 | 0.080 |
Why?
|
Cell Proliferation | 5 | 2011 | 10421 | 0.080 |
Why?
|
Humans | 45 | 2024 | 761098 | 0.070 |
Why?
|
Liposarcoma | 1 | 2010 | 289 | 0.070 |
Why?
|
Chromosomes, Mammalian | 1 | 2008 | 147 | 0.070 |
Why?
|
3T3 Cells | 3 | 1998 | 1083 | 0.070 |
Why?
|
Genomics | 7 | 2015 | 5828 | 0.070 |
Why?
|
Benzoquinones | 1 | 2008 | 198 | 0.070 |
Why?
|
Noonan Syndrome | 1 | 2008 | 120 | 0.070 |
Why?
|
Oncogene Protein v-crk | 2 | 1996 | 6 | 0.070 |
Why?
|
Cloning, Molecular | 1 | 2012 | 4168 | 0.070 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 3 | 1996 | 471 | 0.070 |
Why?
|
Enzyme Inhibitors | 4 | 2015 | 3700 | 0.070 |
Why?
|
Neoplasm Proteins | 2 | 2016 | 3594 | 0.070 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2011 | 1624 | 0.070 |
Why?
|
Lactams, Macrocyclic | 1 | 2008 | 318 | 0.070 |
Why?
|
Tandem Mass Spectrometry | 1 | 2012 | 1186 | 0.070 |
Why?
|
Shc Signaling Adaptor Proteins | 1 | 2005 | 46 | 0.070 |
Why?
|
Models, Molecular | 4 | 2012 | 5413 | 0.070 |
Why?
|
I-kappa B Kinase | 1 | 2007 | 249 | 0.060 |
Why?
|
Tumor Stem Cell Assay | 1 | 2005 | 115 | 0.060 |
Why?
|
DNA Copy Number Variations | 2 | 2013 | 2024 | 0.060 |
Why?
|
Transcription Factors | 5 | 2013 | 12096 | 0.060 |
Why?
|
Chick Embryo | 2 | 1996 | 977 | 0.060 |
Why?
|
Genomic Instability | 1 | 2008 | 709 | 0.060 |
Why?
|
Neoplasms, Experimental | 2 | 2006 | 1225 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2014 | 3634 | 0.060 |
Why?
|
Neuroblastoma | 2 | 2008 | 1246 | 0.050 |
Why?
|
Molecular Targeted Therapy | 2 | 2014 | 2813 | 0.050 |
Why?
|
DNA Mutational Analysis | 2 | 2013 | 4109 | 0.050 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2008 | 725 | 0.050 |
Why?
|
Fibroblasts | 3 | 1998 | 4137 | 0.050 |
Why?
|
Drug Resistance | 1 | 2008 | 1594 | 0.050 |
Why?
|
Cell Line | 6 | 2020 | 15542 | 0.050 |
Why?
|
Sirolimus | 1 | 2009 | 1540 | 0.050 |
Why?
|
Adenosine Triphosphate | 1 | 2008 | 1987 | 0.050 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2013 | 2020 | 0.050 |
Why?
|
Protein Conformation | 4 | 2013 | 3936 | 0.040 |
Why?
|
Cell Line, Transformed | 2 | 2006 | 864 | 0.040 |
Why?
|
Cell Movement | 1 | 2012 | 5195 | 0.040 |
Why?
|
Paclitaxel | 1 | 2008 | 1730 | 0.040 |
Why?
|
Dual Specificity Phosphatase 1 | 2 | 1996 | 42 | 0.040 |
Why?
|
Disulfiram | 1 | 2020 | 63 | 0.040 |
Why?
|
Exons | 1 | 2005 | 2380 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3776 | 0.040 |
Why?
|
MAP Kinase Kinase 1 | 2 | 1998 | 332 | 0.040 |
Why?
|
Genome-Wide Association Study | 2 | 2016 | 12670 | 0.040 |
Why?
|
Sarcoma | 1 | 2010 | 1800 | 0.040 |
Why?
|
Protein Phosphatase 1 | 2 | 1996 | 134 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 3 | 2013 | 4510 | 0.040 |
Why?
|
Tumor Suppressor Proteins | 1 | 2008 | 2802 | 0.040 |
Why?
|
Drug Repositioning | 1 | 2020 | 233 | 0.040 |
Why?
|
Protein Tyrosine Phosphatases | 2 | 1996 | 456 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-raf | 2 | 2014 | 205 | 0.040 |
Why?
|
Protein Prenylation | 1 | 1996 | 70 | 0.030 |
Why?
|
Cells, Cultured | 5 | 2013 | 18926 | 0.030 |
Why?
|
Culture Media, Serum-Free | 1 | 1996 | 148 | 0.030 |
Why?
|
RNA Interference | 3 | 2010 | 2816 | 0.030 |
Why?
|
src Homology Domains | 1 | 1996 | 361 | 0.030 |
Why?
|
Protein Kinases | 2 | 2008 | 1607 | 0.030 |
Why?
|
Loss of Heterozygosity | 2 | 2008 | 663 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2008 | 4405 | 0.030 |
Why?
|
Genes, Tumor Suppressor | 2 | 2010 | 1057 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2005 | 2892 | 0.030 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2008 | 613 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2011 | 8000 | 0.030 |
Why?
|
Epigenesis, Genetic | 1 | 2008 | 3790 | 0.030 |
Why?
|
Interleukin-3 | 2 | 2006 | 425 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2014 | 6919 | 0.030 |
Why?
|
Core Binding Factor beta Subunit | 1 | 2013 | 42 | 0.030 |
Why?
|
Genes, Dominant | 1 | 1996 | 850 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2009 | 1331 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2010 | 2508 | 0.030 |
Why?
|
Genes, ras | 1 | 1996 | 654 | 0.030 |
Why?
|
E1A-Associated p300 Protein | 1 | 2013 | 123 | 0.030 |
Why?
|
Ovarian Neoplasms | 1 | 2010 | 4853 | 0.030 |
Why?
|
Chromosome Deletion | 2 | 2008 | 1386 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2013 | 314 | 0.030 |
Why?
|
Crystallography, X-Ray | 2 | 2008 | 1982 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2013 | 2914 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2011 | 9278 | 0.030 |
Why?
|
HLA-B Antigens | 1 | 2013 | 317 | 0.030 |
Why?
|
Tyrosine | 1 | 1996 | 1422 | 0.020 |
Why?
|
F-Box Proteins | 1 | 2013 | 200 | 0.020 |
Why?
|
TCF Transcription Factors | 1 | 2012 | 138 | 0.020 |
Why?
|
Cluster Analysis | 2 | 2010 | 2706 | 0.020 |
Why?
|
Virus Integration | 1 | 2013 | 304 | 0.020 |
Why?
|
Amino Acid Isomerases | 1 | 1990 | 31 | 0.020 |
Why?
|
Sequence Deletion | 2 | 2007 | 1487 | 0.020 |
Why?
|
Oligopeptides | 1 | 1996 | 1178 | 0.020 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2013 | 371 | 0.020 |
Why?
|
Tumor Cells, Cultured | 2 | 2008 | 6123 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 1998 | 2208 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 1998 | 3725 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2008 | 3591 | 0.020 |
Why?
|
DEAD-box RNA Helicases | 1 | 2012 | 380 | 0.020 |
Why?
|
Autocrine Communication | 1 | 2010 | 169 | 0.020 |
Why?
|
Melanoma | 1 | 2008 | 5694 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2010 | 2864 | 0.020 |
Why?
|
Nomograms | 1 | 2011 | 230 | 0.020 |
Why?
|
3' Untranslated Regions | 1 | 2011 | 514 | 0.020 |
Why?
|
Genotype | 3 | 2008 | 12983 | 0.020 |
Why?
|
Furans | 1 | 2010 | 201 | 0.020 |
Why?
|
Female | 11 | 2014 | 392458 | 0.020 |
Why?
|
src-Family Kinases | 1 | 2011 | 535 | 0.020 |
Why?
|
Diploidy | 1 | 2008 | 133 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2005 | 1681 | 0.020 |
Why?
|
Pyrimidines | 2 | 2011 | 3026 | 0.020 |
Why?
|
G2 Phase | 1 | 2008 | 136 | 0.020 |
Why?
|
Wnt Proteins | 1 | 2012 | 719 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2010 | 410 | 0.020 |
Why?
|
Binding Sites | 2 | 2007 | 5993 | 0.020 |
Why?
|
Procollagen-Proline Dioxygenase | 1 | 2008 | 81 | 0.020 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2012 | 682 | 0.020 |
Why?
|
Open Reading Frames | 1 | 2011 | 811 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2010 | 748 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2009 | 11732 | 0.020 |
Why?
|
Gene Expression Profiling | 3 | 2009 | 9416 | 0.020 |
Why?
|
Proto-Oncogenes | 1 | 2008 | 321 | 0.020 |
Why?
|
PC12 Cells | 1 | 2008 | 317 | 0.020 |
Why?
|
Hedgehog Proteins | 1 | 2012 | 769 | 0.020 |
Why?
|
raf Kinases | 1 | 2008 | 118 | 0.020 |
Why?
|
Papillomaviridae | 1 | 2013 | 1120 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2008 | 613 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2010 | 1761 | 0.020 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2008 | 277 | 0.020 |
Why?
|
beta Catenin | 1 | 2012 | 1039 | 0.020 |
Why?
|
Sequence Analysis, DNA | 2 | 2008 | 4739 | 0.020 |
Why?
|
Blotting, Western | 2 | 2010 | 5033 | 0.020 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2007 | 286 | 0.020 |
Why?
|
DNA Helicases | 1 | 2012 | 851 | 0.020 |
Why?
|
Etoposide | 1 | 2008 | 634 | 0.020 |
Why?
|
Multigene Family | 1 | 2010 | 1075 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 1602 | 0.020 |
Why?
|
Cyclin D1 | 1 | 2008 | 451 | 0.020 |
Why?
|
Precursor Cells, B-Lymphoid | 1 | 2007 | 98 | 0.020 |
Why?
|
Rats | 2 | 2008 | 23713 | 0.020 |
Why?
|
Rhabdoid Tumor | 1 | 2008 | 210 | 0.020 |
Why?
|
Staurosporine | 1 | 2007 | 241 | 0.020 |
Why?
|
Mutant Proteins | 1 | 2008 | 489 | 0.020 |
Why?
|
Pheochromocytoma | 1 | 2008 | 328 | 0.020 |
Why?
|
Molecular Structure | 1 | 2010 | 1875 | 0.020 |
Why?
|
Nuclear Proteins | 2 | 2012 | 5781 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2009 | 1768 | 0.020 |
Why?
|
Molecular Sequence Data | 3 | 2006 | 17598 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2005 | 382 | 0.010 |
Why?
|
Gene Library | 1 | 2007 | 1055 | 0.010 |
Why?
|
Predictive Value of Tests | 2 | 2011 | 15308 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2015 | 2223 | 0.010 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2013 | 1891 | 0.010 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2014 | 2054 | 0.010 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2008 | 620 | 0.010 |
Why?
|
Thiazoles | 1 | 2011 | 1517 | 0.010 |
Why?
|
Drug Synergism | 1 | 2008 | 1756 | 0.010 |
Why?
|
Purines | 1 | 2007 | 609 | 0.010 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2004 | 186 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 1404 | 0.010 |
Why?
|
ROC Curve | 1 | 2011 | 3582 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2012 | 2802 | 0.010 |
Why?
|
Bayes Theorem | 1 | 2011 | 2327 | 0.010 |
Why?
|
Epidermal Growth Factor | 1 | 2005 | 699 | 0.010 |
Why?
|
Protein Transport | 1 | 2008 | 1959 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2008 | 2666 | 0.010 |
Why?
|
Child | 4 | 2012 | 80134 | 0.010 |
Why?
|
Cisplatin | 1 | 2008 | 1651 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2011 | 3409 | 0.010 |
Why?
|
PTEN Phosphohydrolase | 1 | 2008 | 1111 | 0.010 |
Why?
|
Tumor Burden | 1 | 2008 | 1892 | 0.010 |
Why?
|
Papillomavirus Infections | 1 | 2013 | 1615 | 0.010 |
Why?
|
Genetic Loci | 1 | 2011 | 2623 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2010 | 2381 | 0.010 |
Why?
|
Point Mutation | 1 | 2007 | 1593 | 0.010 |
Why?
|
Amino Acid Motifs | 1 | 2004 | 925 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7567 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2012 | 2974 | 0.010 |
Why?
|
Chromosome Aberrations | 1 | 2008 | 1767 | 0.010 |
Why?
|
Models, Biological | 2 | 2008 | 9455 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2012 | 5775 | 0.010 |
Why?
|
Phenotype | 2 | 2009 | 16572 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 2 | 2016 | 17889 | 0.010 |
Why?
|
Down-Regulation | 1 | 2008 | 2915 | 0.010 |
Why?
|
Prognosis | 2 | 2011 | 29672 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2007 | 20981 | 0.010 |
Why?
|
Japan | 1 | 2004 | 1373 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4565 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2008 | 2057 | 0.010 |
Why?
|
DNA Repair | 1 | 2008 | 2041 | 0.010 |
Why?
|
Astrocytes | 1 | 2006 | 1341 | 0.010 |
Why?
|
Algorithms | 2 | 2010 | 14023 | 0.010 |
Why?
|
NF-kappa B | 1 | 2007 | 2475 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 6067 | 0.010 |
Why?
|
DNA Damage | 1 | 2008 | 2443 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2013 | 4021 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2691 | 0.010 |
Why?
|
Histones | 1 | 2008 | 2570 | 0.010 |
Why?
|
Pyridines | 1 | 2010 | 2872 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 1990 | 4189 | 0.010 |
Why?
|
Carrier Proteins | 1 | 1990 | 4933 | 0.010 |
Why?
|
Cell Cycle | 1 | 2005 | 2926 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2004 | 13404 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11066 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1996 | 849 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2013 | 22157 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2008 | 9518 | 0.010 |
Why?
|
Aged | 3 | 2014 | 169266 | 0.010 |
Why?
|
Time Factors | 1 | 1996 | 39953 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2007 | 5103 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2008 | 14393 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 1990 | 7405 | 0.010 |
Why?
|
Glioblastoma | 1 | 2006 | 3481 | 0.010 |
Why?
|
Male | 4 | 2012 | 360675 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2006 | 14676 | 0.010 |
Why?
|
Peptidylprolyl Isomerase | 1 | 1990 | 97 | 0.010 |
Why?
|
Cohort Studies | 1 | 2012 | 41486 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1990 | 1053 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2008 | 64670 | 0.010 |
Why?
|
Risk Assessment | 1 | 2011 | 24013 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2008 | 18217 | 0.000 |
Why?
|
Neurons | 1 | 2008 | 9435 | 0.000 |
Why?
|
Cytosol | 1 | 1990 | 883 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2012 | 58946 | 0.000 |
Why?
|
Tacrolimus | 1 | 1990 | 735 | 0.000 |
Why?
|
Middle Aged | 2 | 2012 | 220835 | 0.000 |
Why?
|
Adult | 2 | 2012 | 221083 | 0.000 |
Why?
|
Cattle | 1 | 1990 | 3819 | 0.000 |
Why?
|
Risk Factors | 1 | 2011 | 74219 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2009 | 36418 | 0.000 |
Why?
|
Saccharomyces cerevisiae | 1 | 1990 | 2667 | 0.000 |
Why?
|
B-Lymphocytes | 1 | 1990 | 4744 | 0.000 |
Why?
|
United States | 1 | 2004 | 72337 | 0.000 |
Why?
|
T-Lymphocytes | 1 | 1990 | 10203 | 0.000 |
Why?
|